Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corneal tissue regeneration is the process by which the cornea repairs itself following injury or disease. It involves a coordinated response of cellular proliferation, migration, differentiation, and extracellular matrix remodeling, regulated by growth factors, cytokines, and extracellular matrix components. Key cellular players include limbal stem cells, corneal epithelial cells, and keratocytes. Therapeutic approaches aim to replenish lost stem cell populations or enhance endogenous repair mechanisms, while challenges remain in restoring native tissue architecture without inducing scarring.
Varies depending on the specific therapy; generally involves promoting cell migration, proliferation, and differentiation, reducing inflammation, and supporting extracellular matrix remodeling.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal Tissue Regeneration.